Tyler Golato
Co-Initiator ~ VitaDAO · Partner ~ Triplicate · Co-Founder ~ Molecule · Co-Initiator ~ BIO Protocol
Tyler Golato는 Triplicate의 파트너이자 약물 개발을 위한 오픈소스 프로토콜인 Molecule의 공동 창립자입니다. 이전에는 Dr. David M. Wilson III와 Dr. Vilhelm Bohr의 지도 아래 국립 노화 연구소(NIH/NIA/IRP)에서 내인성 DNA 손상 복구, 특히 노화와 관련된 연구에 집중했습니다. 또한 Tyler는 VitaDAO와 bio.xyz를 공동 창립했습니다. DeSci에서 일하기 전, Tyler는 생화학자, 분자생물학자, 생물노화학자로서 뛰어난 초기 경력을 쌓았습니다.
현재 역할
투자
뉴스 언급
May in the Biosphere 🌐 - PeptAI Ignition Sale: 32x+ oversubscribed, 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims now live in the Bio app. Next: first on-chain wet-lab attestation via Molecule Labs in Q2. - BIO on Robinhood: $BIO is now tradable on @RobinhoodApp, bringing
The chemical universe is too massive for brute-force computing. "It would take over 170 years to brute force this data set by running inference on every single possible molecule." @metanova_labs #SN68 "Nova blueprint" incentivizes global miners to design and open-source their algorithmic shortcut
hot take: a single water molecule isn't wet. but two are.
This AI Reads Your Chemistry Instructions and Finds the Best Way to Build You a Molecule
For a decade, AI, Web3, and Bio have scaled as parallel frontiers, but that era is ending.The defining companies of the
For a decade, AI, Blockchain, and Bio have scaled as parallel frontiers - but that era is ending.The defining companies
We're excited to announce The Convergence, YZi Labs' flagship conference of the year. On May 12 at the iconic Computer H
The scientist who would have studied your disease probably chose a different problem.
Most people describe biotech companies as a jump from discovery to application.
Prompt-to-DeFi Strategist Challenge: BNB Chain Edition